Sharon Lewin on requirements of a cell- and gene-based therapy product for HIV cure

Sharon Lewin (Peter Doherty Institute for Infection and Immunity, Melbourne, Australia) joins Deputy Editor, Adrian Gonzalez to talk about the requirements and challenges to develop a product for HIV cure based on cell and gene therapies. Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00277-7/fulltext?dgcid=buzzsprout_icw_podcast_general_lanhiv Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv